China NMPA Product Recall - Accessories of Cardioblate Surgical Ablation System

On July 29, 2022, the National Medical Products Administration (NMPA) formally announced a voluntary Class I recall initiated by Medtronic, Inc. This significant action targets the Accessories of the Cardioblate Surgical Ablation System, identified by Registration Certificate No.: 国械注进20173011933. The impetus for this recall stems from a critical manufacturing flaw: the potential for clamp tip breakage within these accessories.

The classification of this event as a Class I recall by the NMPA is particularly noteworthy. This designation is reserved for situations where there is a reasonable probability that the use of, or exposure to, the defective product will lead to serious adverse health consequences or, in severe cases, death. Such a classification underscores the high potential risk posed by the malfunctioning components to patient safety during surgical procedures. Medtronic, Inc., in collaboration with Medtronic (Shanghai) Management Co., Ltd., is responsible for executing this recall.

Specific details regarding the affected product models, their specifications, and relevant batch numbers are comprehensively outlined in the "Medical Device Recall Report Form" attached to the NMPA's announcement. This proactive and essential measure taken by Medtronic, under the strict regulatory framework of the NMPA, highlights the imperative for medical device companies to maintain rigorous quality control and respond swiftly to product safety concerns, thereby safeguarding public health.